Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme

2007 ◽  
Vol 124 (3) ◽  
pp. 163-171 ◽  
Author(s):  
Mina Nikanjam ◽  
Andrew R. Gibbs ◽  
C. Anthony Hunt ◽  
Thomas F. Budinger ◽  
Trudy M. Forte
2007 ◽  
Vol 328 (1) ◽  
pp. 86-94 ◽  
Author(s):  
Mina Nikanjam ◽  
Eleanor A. Blakely ◽  
Kathleen A. Bjornstad ◽  
Xiao Shu ◽  
Thomas F. Budinger ◽  
...  

2018 ◽  
Vol 6 (18) ◽  
pp. 2758-2768 ◽  
Author(s):  
Hongzhao Qi ◽  
Lijun Yang ◽  
Xueping Li ◽  
Qi Zhan ◽  
Donglin Han ◽  
...  

A new exosome-related drug delivery vehicle was explored based on the “STOP” criteria, dramatically promoting the clinical translation of exosomes.


2020 ◽  
Vol 27 ◽  
pp. 102196
Author(s):  
Xiuying Yang ◽  
Dongliang Zhai ◽  
Jia Song ◽  
Rui Qing ◽  
Bochu Wang ◽  
...  

2019 ◽  
Vol 7 (32) ◽  
pp. 4927-4932 ◽  
Author(s):  
Shuang Fu ◽  
Fei Li ◽  
Mingsong Zang ◽  
Zherui Zhang ◽  
Yuancheng Ji ◽  
...  

A new highly efficient targeting drug delivery vehicle based on diselenium-containing ultrathin polymer nanocapsules was designed and prepared.


2013 ◽  
Vol 145 ◽  
pp. 290-296 ◽  
Author(s):  
Avanthi Althuri ◽  
Jincy Mathew ◽  
Raveendran Sindhu ◽  
Rintu Banerjee ◽  
Ashok Pandey ◽  
...  

2016 ◽  
Vol 7 (40) ◽  
pp. 6178-6188 ◽  
Author(s):  
Guocan Yu ◽  
Run Zhao ◽  
Dan Wu ◽  
Fuwu Zhang ◽  
Li Shao ◽  
...  

Here we construct the first pillararene-based amphiphilic supramolecular brush copolymer, which can be utilized as a targeting self-imaging drug delivery vehicle.


RSC Advances ◽  
2016 ◽  
Vol 6 (67) ◽  
pp. 62556-62571 ◽  
Author(s):  
Lubna Sheikh ◽  
Sucheta Tripathy ◽  
Suprabha Nayar

Nucleation and growth of hydroxyapatite nanoparticles in the presence of different matrices acting as a potent drug delivery vehicle.


Nanomedicine ◽  
2020 ◽  
Vol 15 (19) ◽  
pp. 1861-1871
Author(s):  
Lorenzo Taiarol ◽  
Beatrice Formicola ◽  
Roberta Dal Magro ◽  
Silvia Sesana ◽  
Francesca Re

Glioblastoma multiforme is a serious medical issue in the brain oncology field due to its aggressiveness and recurrence. Immunotherapy has emerged as a valid approach to counteract the growth and metastasization of glioblastoma multiforme. Among the different innovative approaches investigated, nanoparticles gain attention because of their versatility which is key in allowing precise targeting of brain tumors and increasing targeted drug delivery to the brain, thus minimizing adverse effects. This article reviews the progress made in this field over the past 2 years, focusing on nonspherical and biomimetic particles and on vectors for the delivery of nucleic acids. However, challenges still need to be addressed, considering the improvement of the particles passage across the blood–meningeal barrier and/or the blood–brain barrier, promoting the clinical translatability of these approaches.


Sign in / Sign up

Export Citation Format

Share Document